RecQ mediated genome instability 2 (<i>RMI2</i>): a potential prognostic and immunological biomarker for pan-cancers

Wei Wei; Xiaomei Ying; Liang Chen; Qingmei Sun; Xiaohuan Lu; Yang Xia; Rubin Xu; Zhechen Zhu; Dong Zhang; Qikai Tang; Li Li; Jiaheng Xie; Hongzhu Yu

doi:doi:10.18632/aging.204076

← Back

Research Paper Volume 14, Issue 9 pp 4107—4136

RecQ mediated genome instability 2 (RMI2): a potential prognostic and immunological biomarker for pan-cancers

Figure 9. KEGG enrichment plots from GSEA in various cancers. P<0.05 and enrichment results of more than 5 were considered for shown. (A) Enrichment results of KEGG pathway in cancer ACC. (B) Enrichment results of KEGG pathway in cancer OV. (C) Enrichment results of KEGG pathway in cancer PCPG. (D) Enrichment results of KEGG pathway in cancer PRAD. (E) Enrichment results of KEGG pathway in cancer READ. (F) Enrichment results of KEGG pathway in cancer SKCM. (G) Enrichment results of KEGG pathway in cancer STAD. (H) Enrichment results of KEGG pathway in cancer UCEC. (I) Enrichment results of KEGG pathway in cancer UVM.